Acasti Pharma receives $750,000 grant from National Research Council of Canada
Acasti Pharma (CVE: ACST) Co-founder COO and Chief Scientific Officer Dr, Pierre Lemieux joined Steve Darling from Proactive Vancouver on Skype to discuss the company has received a sizable grant from the Canadian Government to help their drug development work.
Lemieux telling Proactive what the money will be used for and also an update on the development of CaPre.
Quick facts: Acasti Pharma Inc
Market Cap: $241.73 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Acasti Pharma Inc named herein, including the promotion by the Company of Acasti Pharma Inc in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE